Algo version: 0.98b
Hisamitsu Pharmaceutical is listed at the PNK Exchange
Hisamitsu Pharmaceutical [HTSUF]
PNK Sector: Healthcare Industry:Drug Manufacturers Specialty Generic

Is Hisamitsu Pharmaceutical stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Hisamitsu Pharmaceutical pays dividends. Last time was Thursday 1st of May 2025 where the investors holding the stock on Thursday 27th of February 2025 were paid $0.29088 per share. Over the last 25 times between 2011 and 2025, Hisamitsu Pharmaceutical has paid $7.43235606 with an average of $0.3 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Hisamitsu Pharmaceutical 10 years ago, but if you had invested on Friday 22nd of November 2019 when the price was $38.50, you would have made a loss of $-13.94 per share or -36.21%

We do not have enough data to give you this answer.

Hisamitsu Pharmaceutical has no real debt, which is good in periods of high inflation. With a high cash flow to debt ratio of 4.46, the company's ability to pay off the debt is good. Hisamitsu Pharmaceutical has a good net profit margin of 9.75% and should have high tolerances against inflation.

We have calculated the inflation risk for Hisamitsu Pharmaceutical to be low [0.1 of 1]

US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.41 and is up 0.05 over the last 30 days.